|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-10.66/-0.08
|
Enterprise Value
323.58K
|
Balance Sheet |
Book Value Per Share
2.96
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
0
|
Operating Revenue Per Share
--
|
Industry Comparison
|
||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/14 03:46 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
"Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (""OAK"") as part of its OA-201 development program (""OA-201 program"" or ""OA-201"")." |